PROMOTE-ALI前瞻性多中心观察研究:患者特征对急性下肢缺血治疗策略选择与结局的影响
PROMOTE-ALI研究纳入2021年12月1日至2023年8月31日欧洲705例急性下肢缺血患者,评估治疗策略选择的影响因素及短期结局。开放手术占55.7%,杂交治疗占20.9%,血管内治疗占19.1%;完成术中造影的开放手术病例再干预率显著降低(6.16% vs 13.52%;P = .02)。各治疗方式无截肢生存率相当,强调个体化治疗。
要点
- 开放手术占55.7%,杂交治疗占20.9%,血管内治疗占19.1%。
- 开放手术完成术中造影者再干预率6.16% vs 未完成者13.52%(P = .02)。
- 血管内治疗再干预率32.6%、出血率5.2%,高于开放手术和杂交治疗。
核心结论
- 患者特征、疾病病因和手术因素显著影响急性下肢缺血的治疗选择。
- 开放手术仍是基本治疗方式,杂交技术处理复杂病变,血管内治疗更常用于既往血运重建失败者但再干预风险较高。
- 各治疗方式无截肢生存率相当,强调个体化方法和治疗方案优化的重要性。
研究设计与样本
- PROMOTE-ALI为前瞻性多中心观察研究,纳入2021年12月1日至2023年8月31日欧洲705例急性下肢缺血患者。
- 主要终点为识别影响治疗选择的术前预测因素,采用广义线性混合模型分析,以入组中心为随机截距。
- 次要终点包括30天和90天无截肢生存率、免于靶肢体再干预、临床结局、并发症和生存率,采用Kaplan-Meier分析评估概率。
主要发现
- 705例中开放手术占55.7%,杂交治疗占20.9%,血管内治疗占19.1%。
- 开放手术病例中50.1%完成术中造影,完成者再干预率6.16% vs 未完成者13.52%(P = .02)。
- 外周动脉疾病患者更倾向选择血管内治疗(60.0%)和杂交治疗(60.5%)vs 开放手术(46.3%)(P = .05和P = .03)。
- 既往同侧血运重建患者更倾向选择血管内治疗(57.8%)和杂交治疗(48.3%)vs 开放手术(32.1%)(P < .001和P < .02)。
- 心脏节律失常患者更倾向选择开放手术(38.4%)vs 血管内治疗(16.3%)和杂交治疗(13.6%)(P = .004和P = .002)。
临床怎么用
- 作者认为开放手术仍是基本治疗方式,杂交技术用于处理复杂病变。
- 作者认为血管内治疗更常用于既往血运重建失败者,但再干预风险较高。
- 作者认为各治疗方式无截肢生存率相当,强调个体化方法和治疗方案优化的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute lower limb ischemia (ALI) is a vascular emergency requiring prompt intervention to prevent limb loss and mortality. Treatment strategies have evolved from open surgical revascularization (OSR) and thrombolysis-dominated endovascular therapy (EVT) with advanced thrombectomy devices and hybrid approaches, yet optimal management remains debated. PROMOTE-ALI (Prospective Multicentre Observational Study Evaluating Acute Lower Limb Ischaemia) evaluates contemporary treatment practices, factors influencing modality selection, and short-term outcomes in ALI across Europe. METHODS: The PROMOTE-ALI registry included patients from December 1, 2021, to August 31, 2023. The primary end point was identifying preoperative predictors influencing treatment choice. Secondary end points included 30-day and 90-day amputation-free survival (AFS), freedom from target limb reintervention, clinical outcomes, complications, and survival. Predictors of treatment were analyzed with generalized linear mixed model with random intercept for inclusion site. Kaplan-Meier analysis evaluated the probability for AFS, freedom from major amputation, and survival. RESULTS: Among 705 cases, OSR (55.7%) was the predominant treatment, followed by hybrid (20.9%) and EVT (19.1%). Completion angiography was performed in 50.1% of OSR cases, significantly reducing reintervention rates (6.16% vs 13.52%; P = .02). EVT and hybrid therapy were favored in patients with peripheral artery disease (60.0% and 60.5% vs 46.3% OSR; P = .05 and P = .03) and prior ipsilateral revascularizations (57.8% and 48.3% vs 32.1%; P < .001 and P < .02). OSR was preferred in patients with cardiac dysrhythmia (38.4% vs 16.3% EVT and 13.6% hybrid; P = .004 and P = .002). EVT patients had higher reintervention (32.6%) and bleeding rates (5.2%) compared with OSR (8.9%, 1.0%) and hybrid therapy (15.0%, 1.4%; P < .001 and P = .01). CONCLUSIONS: This study highlights evolving ALI treatment patterns in Europe. Patient characteristics, disease etiology, and procedural factors significantly influence ALI treatment selection. Although OSR remains essential, hybrid techniques address complex lesions, and EVT is preferred in failed prior revascularizations, although with higher reintervention risks. Comparable AFS across modalities underscores the importance of individualized approaches and refinement of treatment protocols to optimize outcomes.
引用
- Doukas P, Enzmann FK, Noronen K, et al. Insights from the prospective multicentre observational study evaluating acute lower limb ischemia on the influence of patient characteristics on treatment strategy selection and outcomes. J Vasc Surg. 2025. PMID: 40204031. doi:10.1016/j.jvs.2025.03.476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。